Prevalence of HPV infection and other risk factors in a Fijian population

Infectious Agents and Cancer

Volumn 9, Issue 1, 2014, Pages

  Foliaki, Sunia ^a   Brewer, Naomi ^a   Pearce, Neil ^a,b   Snijders, Peter J F ^c   Meijer, Chris J L M ^c   Waqatakirewa, Lepani ^d   Clifford, Gary M ^e   Franceschi, Silvia ^e  

^a MASSEY UNIVERSITY   (New Zealand)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Ministry of Health   (Nauru)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cervical neoplasia; Cervical screening; Fiji; HPV genotypes; Human papillomavirus (HPV)

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DISEASE ASSOCIATION; DIVORCED WOMAN; EXTRAMARITAL SEX; FEMALE; FIJI; FOLLOW UP; HEALTH SURVEY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; MAJOR CLINICAL STUDY; MARRIED WOMAN; PRIORITY JOURNAL; RISK FACTOR; SEPARATED PERSON; VERRUCA VULGARIS; WART VIRUS; WIDOWED PERSON;

EID: 84901987162     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-9-14     Document Type: Article

References (26)

1. Health research in the Pacific. Foliaki S, Fakakovikaetau T, Waqatakirewa L, Pearce N, Pac Health Dialog 2004 11 2 199 203 16281699
2. Cancer in Pacific people in New Zealand: a descriptive study. Foliaki S, Jeffreys M, Wright C, Blakey K, Pearce N, Pac Health Dialog 2004 11 2 94 100
3. Cancer disparities in indigenous Polynesian populations: Maori, Native Hawaiians, and Pacific people. Dachs GU, Currie MJ, McKenzie F, Jeffreys M, Cox B, Foliaki S, Le Marchand L, Robinson BA, Lancet Oncol 2008 9 5 473 84 10.1016/S1470-2045(08)70127-X 18452858 (Pubitemid 351618082)
4. Cancer incidence in four pacific countries: Tonga, Fiji Islands, Cook Islands and Niue. Foliaki S, Best D, Akau'ola S, Cheng S, Borman B, Pearce N, Pac Health Dialog 2011 17 1 21 32 23008968
5. 2007 Census of Population and Housing. Fiji Islands Bureau of Statistics, Suva: Government of Fiji Islands 2007
6. Burden of Cervical Cancer and Cervical Intraepithelial Neoplasia in Fiji (2004-2007). Law I, Melbourne: University of Melbourne World Health Organization Mission Report. 2007
7. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, Int J Cancer 2010 127 12 2893 917 10.1002/ijc.25516 21351269
8. Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Fiji. Tabrizi SN, Law I, Buadromo E, Stevens MP, Fong J, Samuela J, Patel M, Mulholland EK, Russell FM, Garland SM, Sex Health 2011 8 3 338 42 10.1071/SH10083 21851773
9. Prevalence of cervical human papillomavirus (HPV) infection in Vanuatu. Aruhuri B, Tarivonda L, Tenet V, Sinha R, Snijders PJ, Clifford G, Pang J, McAdam M, Meijer CJ, Frazer IH, Franceschi S, Cancer Prev Res (Phila) 2012 5 5 746 53 10.1158/1940-6207.CAPR-11-0515 22427345
10. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, Ning L, Killeen J, Kamemoto L, Hernandez BY, Cancer Res 2008 68 21 8813 24 10.1158/0008-5472.CAN-08-1380 18974124
11. Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. Garland SM, Brotherton JM, Condon JR, McIntyre PB, Stevens MP, Smith DW, et al. BMC Med 2011 9 104 10.1186/1741-7015-9-104 21910918
12. HPV infection in women with and without cervical cancer in Conakry, Guinea. Keita N, Clifford GM, Koulibaly M, Douno K, Kabba I, Haba M, Sylla BS, van Kemenade FJ, Snijders PJ, Meijer CJ, Franceschi S, Br J Cancer 2009 101 1 202 8 10.1038/sj.bjc.6605140 19536089
13. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJ, Meijer CJ, Franceschi S, Pawlita M, Cancer Epidemiol Biomarkers Prev 2008 17 7 1731 8 10.1158/1055-9965.EPI-07-2796 18628425
14. International correlation between human papillomavirus prevalence and cervical cancer incidence. Maucort-Boulch D, Franceschi S, Plummer M, Cancer Epidemiol Biomarkers Prev 2008 17 3 717 20 10.1158/1055-9965.EPI-07-2691 18349293 (Pubitemid 351469225)
15. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX, Lancet Infect Dis 2007 7 7 453 9 10.1016/S1473-3099(07)70158-5 17597569 (Pubitemid 46962343)
16. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Vaccarella S, Herrero R, Dai M, Snijders PJ, Meijer CJ, Thomas JO, Hoang Anh PT, Ferreccio C, Matos E, Posso H, de Sanjose S, Shin HR, Sukvirach S, Lazcano-Ponce E, Ronco G, Rajkumar R, Qiao YL, Munoz N, Franceschi S, Cancer Epidemiol Biomarkers Prev 2006 15 11 2148 53 10.1158/1055-9965.EPI-06-0556 17119039 (Pubitemid 44877039)
17. A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States. Gravitt PE, Rositch AF, Silver MI, Marks MA, Chang K, Burke AE, Viscidi RP, J Infect Dis 2013 207 2 272 80 10.1093/infdis/jis660 23242540
18. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao YL, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Meijer CJ, Munoz N, Int J Cancer 2006 119 11 2677 84 10.1002/ijc.22241 16991121 (Pubitemid 44691325)
19. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. de Roda Husman AM, Snijders PJ, Stel HV, van den Brule AJ, Meijer CJ, Walboomers JM, Br J Cancer 1995 72 2 412 7 10.1038/bjc.1995.347 7543772
20. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ, Int J Cancer 2000 87 2 221 7 10.1002/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2 10861478 (Pubitemid 30434349)
21. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM, Int J Cancer 2011 128 4 927 35 10.1002/ijc.25396 20473886
22. Chapter 8: Screening for cervical cancer in developing countries. Denny L, Quinn M, Sankaranarayanan R, Vaccine 2006 24 Suppl 3 3/71 7
23. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH, Peck RB, Li L, Chen F, Pan QJ, Lorincz AT, Lancet Oncol 2008 9 10 929 36 10.1016/S1470-2045(08)70210-9 18805733
24. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, Fayette JM, Cherian J, Lancet 2007 370 9585 398 406 10.1016/S0140-6736(07)61195-7 17679017 (Pubitemid 47176655)
25. Different cervical cancer screening approaches in a Chinese multicentre study. Li N, Shi JF, Franceschi S, Zhang WH, Dai M, Liu B, Zhang YZ, Li LK, Wu RF, De Vuyst H, Plummer M, Qiao YL, Clifford G, Br J Cancer 2009 100 3 532 7 10.1038/sj.bjc.6604840 19127262
26. Cancer Incidence in Five Continents Lyon: Volume IX (IARC Scientific Publications No. 160). IARC, Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P, 2007